New Novavax Covid Vaccine

FDA, Covid

FDA Panel Backs New COVID Vaccines Aimed at Dominant Strain

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) also discussed the need to target the long-simmering BA.3.2 variant, also known as "cicada," though most expressed confidence that targeting XFG was the right way to go.

· 1d

FDA panel lays out new Covid vaccine formulation recommendation

· 2d · on MSN

FDA advisers recommend COVID vaccines be updated to target current dominant variant

Inc

FDA Approves New Covid Vaccine

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the ...

Reuters

Novavax shares soar after FDA request raises hope for COVID vaccine approval

Novavax aims to convert emergency authorization to full approval FDA's request boosts Novavax shares by 18% Analysts confident in Novavax's approval despite past hurdles April 23 (Reuters) - ...

The Gazette

Iowans contributed to research behind new Novavax COVID vaccine

IOWA CITY — News this week that Americans now have a fourth COVID-19 vaccine option — one closer to more traditional vaccines used to combat flu, for example — came about thanks, in part, to ...

koaa

Novavax says its COVID-19 vaccine is effective in children as young as 12

Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12. The Maryland-based company makes a protein-based vaccine that's been cleared for use in adults in parts ...

24d

Novavax beats first-quarter revenue estimates on strength in vaccine deals

Novavax on Wednesday beat Wall Street estimates for first-quarter revenue, as upfront and milestone payments from vaccine supply and licensing deals helped offset pressure from sagging demand, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results